Source link : https://newshealth.biz/health-news/upfront-t-dxd-combo-nearly-doubles-pfs-in-her2-positive-breast-cancer/
(MedPage Today) — At the recent American Society of Clinical Oncology (ASCO) annual meeting, interim results from the DESTINY-Breast09 trial highlighted a potential shift in frontline treatment for metastatic HER2-positive breast cancer. The combination… Source link : https://www.medpagetoday.com/meetingcoverage/ascovideopearlsbreastca/116216 Author : Publish date : 2025-06-24 15:23:00 Copyright for syndicated content belongs to the linked Source.
The post Upfront T-DXd Combo Nearly Doubles PFS in HER2-Positive Breast Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-24 15:23:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8